Role of A-kinase anchor protein 12 in chronic liver diseases

Haijian DONG; Hui LI; Yujing TAO; Jialing GUO; Yuru ZHONG; Zijian ZENG

doi:10.3969/j.issn.1001-5256.2023.03.037

Volume 39 Issue 3

Mar. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(3): 718-722

PDF( 1987 KB)

Role of A-kinase anchor protein 12 in chronic liver diseases

DOI: 10.3969/j.issn.1001-5256.2023.03.037

Haijian DONG^{1, 2},
Hui LI^{1
,
,
,},
Yujing TAO^{1, 2},
Jialing GUO^{1, 2},
Yuru ZHONG^{1, 2},
Zijian ZENG^{1, 2}

1.
Central Laboratory, The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
2.
School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China

Research funding:

Sichuan Science and Technology Program (2020YFS0379)

More Information

Corresponding author: LI Hui, 1400124746@qq.com (ORCID: 0000-0002-5919-1396)
Received Date: 2022-07-06
Accepted Date: 2022-08-08
Published Date: 2023-03-20

Abstract

Abstract

A-kinase anchor protein 12 (AKAP12) is a scaffold protein that improves the specificity and efficiency of spatio-temporal signals by assembling intracellular signal proteins into specific complexes. In recent years, the role of AKAP12 in chronic liver diseases has attracted more and more attention. This article introduces the physiological functions of AKAP12 and reviews the role of AKAP12 in chronic liver diseases, in order to lay a foundation for the use of AKAP12 small molecule as a new therapeutic target for chronic liver diseases.
- A Kinase Anchor Proteins,
- Liver Cirrhosis,
- Non-alcoholic Fatty Liver Disease,
- Liver Diseases, Alcoholic,
- Carcinoma, Hepatocellular

FullText(HTML)

References(31)

References

[1]	QASIM H, MCCONNELL BK. AKAP12 signaling complex: impacts of compartmentalizing cAMP-dependent signaling pathways in the heart and various signaling systems[J]. J Am Heart Assoc, 2020, 9(13): e016615. DOI: 10.1161/JAHA.120.016615.
[2]	NAUERT JB, KLAUCK TM, LANGEBERG LK, et al. Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein[J]. Curr Biol, 1997, 7(1): 52-62. DOI: 10.1016/s0960-9822(06)00027-3.
[3]	MUKHERJEE M, RATNAYAKE I, JANGA M, et al. Notch signaling regulates Akap12 expression and primary cilia length during renal tubule morphogenesis[J]. FASEB J, 2020, 34(7): 9512-9530. DOI: 10.1096/fj.201902358RR.
[4]	NELSON PJ, GELMAN IH. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response[J]. Mol Cell Biochem, 1997, 175(1-2): 233-241. DOI: 10.1023/a:1006836003758.
[5]	LIN X, GELMAN IH. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis[J]. Cancer Res, 1997, 57(11): 2304-2312.
[6]	KWON HB, CHOI YK, LIM JJ, et al. AKAP12 regulates vascular integrity in zebrafish[J]. Exp Mol Med, 2012, 44(3): 225-235. DOI: 10.3858/emm.2012.44.3.017.
[7]	TAKASE H, HAMANAKA G, OHTOMO R, et al. Roles of A-kinase anchor protein 12 in astrocyte and oligodendrocyte precursor cell in postnatal corpus callosum[J]. Stem Cell Rev Rep, 2021, 17(4): 1446-1455. DOI: 10.1007/s12015-021-10118-w.
[8]	LEE SW, KIM WJ, CHOI YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier[J]. Nat Med, 2003, 9(7): 900-906. DOI: 10.1038/nm889.
[9]	CHOI YK, KIM KW. AKAP12 in astrocytes induces barrier functions in human endothelial cells through protein kinase Czeta[J]. FEBS J, 2008, 275(9): 2338-2353. DOI: 10.1111/j.1742-4658.2008.06387.x.
[10]	KHURANA A, SAYED N, ALLAWADHI P, et al. It's all about the spaces between cells: role of extracellular matrix in liver fibrosis[J]. Ann Transl Med, 2021, 9(8): 728. DOI: 10.21037/atm-20-2948.
[11]	WEISSMVLLER T, GLOVER LE, FENNIMORE B, et al. HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function[J]. FASEB J, 2014, 28(1): 256-264. DOI: 10.1096/fj.13-238741.
[12]	WU X, LUO Y, WANG S, et al. AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway[J]. Redox Biol, 2022, 53: 102328. DOI: 10.1016/j.redox.2022.102328.
[13]	LI Z, HU J, GUO J, et al. SSeCKS/Gravin/AKAP12 inhibits PKCζ-mediated reduction of ERK5 transactivation to prevent endotoxin-induced vascular dysfunction[J]. Cardiovasc Toxicol, 2019, 19(4): 372-381. DOI: 10.1007/s12012-018-09502-9.
[14]	BENZ PM, DING Y, STINGL H, et al. AKAP12 deficiency impairs VEGF-induced endothelial cell migration and sprouting[J]. Acta Physiol (Oxf), 2020, 228(1): e13325. DOI: 10.1111/apha.13325.
[15]	WALKER-GRAY R, KLUSSMANN E. The role of AKAP12 in coordination of VEGF-induced endothelial cell motility[J]. Acta Physiol (Oxf), 2020, 228(1): e13359. DOI: 10.1111/apha.13359.
[16]	YING HZ, CHEN Q, ZHANG WY, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)[J]. Mol Med Rep, 2017, 16(6): 7879-7889. DOI: 10.3892/mmr.2017.7641.
[17]	DI SARIO A, BENDIA E, SVEGLIATI-BARONI G, et al. Rearrangement of the cytoskeletal network induced by platelet-derived growth factor in rat hepatic stellate cells: role of different intracellular signalling pathways[J]. J Hepatol, 2002, 36(2): 179-190. DOI: 10.1016/s0168-8278(01)00242-2.
[18]	YOU T, FAN Y, LI Q, et al. Increased SSeCKS expression in rat hepatic stellate cells upon activation in vitro and in vivo[J]. Inflammation, 2013, 36(6): 1415-1423. DOI: 10.1007/s10753-013-9681-4.
[19]	LEE HS, CHOI J, SON T, et al. A-kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide-induced liver injury[J]. Oncol Lett, 2018, 16(5): 5907-5915. DOI: 10.3892/ol.2018.9396.
[20]	LEE HS, CHOI J, SON T, et al. Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution[J]. Exp Mol Med, 2018, 50(4): 1-13. DOI: 10.1038/s12276-018-0074-5.
[21]	BARNETT ME, MADGWICK DK, TAKEMOTO DJ. Protein kinase C as a stress sensor[J]. Cell Signal, 2007, 19(9): 1820-1829. DOI: 10.1016/j.cellsig.2007.05.014.
[22]	YANG JI, YOON JH, BANG YJ, et al. Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(1): G126-G132. DOI: 10.1152/ajpgi.00299.2009.
[23]	ZHANG LY, SHAO JG, XIAO F, et al. Mechanism of expression of the Src family kinases (Fgr, Hck, Lyn) and SSeCKS in non-alcoholic steatohepatitis[J]. Chin J Hepatol, 2015, 23(5): 363-367. DOI: 10.3760/cma.j.issn.1007-3418.2015.05.009. 张玲燕, 邵建国, 肖锋, 等. Src家族相关激酶(Fgr, Hck, Lyn)/SSeCKS在非酒精性脂肪性肝炎中的作用机制[J]. 中华肝脏病杂志, 2015, 23(5): 363-367. DOI: 10.3760/cma.j.issn.1007-3418.2015.05.009.
[24]	FAN Q, YIN X, RABABA'H A, et al. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis[J]. Am J Physiol Heart Circ Physiol, 2019, 317(4): H793-H810. DOI: 10.1152/ajpheart.00215.2019.
[25]	RAMANI K, TOMASI ML, BERLIND J, et al. Role of A-kinase anchoring protein phosphorylation in alcohol-induced liver injury and hepatic stellate cell activation[J]. Am J Pathol, 2018, 188(3): 640-655. DOI: 10.1016/j.ajpath.2017.11.017.
[26]	ZHANG J, PIAO HY, GUO S, et al. LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12[J]. Int J Clin Oncol, 2020, 25(4): 570-583. DOI: 10.1007/s10147-019-01604-w.
[27]	GELMAN IH. Emerging roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis[J]. Genes Cancer, 2010, 1(11): 1147-1156. DOI: 10.1177/1947601910392984.
[28]	HAN S, WANG L, SUN L, et al. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12[J]. Biomed Pharmacother, 2020, 122: 109754. DOI: 10.1016/j.biopha.2019.109754.
[29]	LAN X, WU N, WU L, et al. The human novel gene LNC-HC inhibits hepatocellular carcinoma cell proliferation by sequestering hsa-miR-183-5p[J]. Mol Ther Nucleic Acids, 2020, 20: 468-479. DOI: 10.1016/j.omtn.2020.03.008.
[30]	XIA W, NI J, ZHUANG J, et al. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12[J]. Int J Biochem Cell Biol, 2016, 71: 1-11. DOI: 10.1016/j.biocel.2015.11.017.
[31]	YANG L, CAO J, WEI J, et al. Antiproliferative activity of berberine in HepG2 cells via inducing apoptosis and arresting cell cycle[J]. Food Funct, 2021, 12(23): 12115-12126. DOI: 10.1039/d1fo02783b.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1)

Get Citation

PDF

XML

Article Metrics

Article views (343) PDF downloads(88)

Role of A-kinase anchor protein 12 in chronic liver diseases

DOI: 10.3969/j.issn.1001-5256.2023.03.037

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Role of A-kinase anchor protein 12 in chronic liver diseases

DOI: 10.3969/j.issn.1001-5256.2023.03.037

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content